Press Release Contact
Press release:
Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
January 10, 2025, 13:00 GMT
For questions about this press release, please contact the person or organization listed below.